Sulzer aims to take the wear out of joints:
This article was originally published in Clinica
Swiss company Sulzer Orthopaedics has licensed from the Massachusetts Institute of Technology and Massachusetts General Hospital in the US a new ultra low wear material to improve the performance of replacement joints. The deal gives Sulzer worldwide rights to a polyethylene developed in Massachusetts. The new polyethylene material aims to reduce the incidence of osteolysis, the number one cause of hip implant failure where bone is eroded around the implant. The material will be used to line acetabular inserts, cup like metal implants into which the ball shaped femoral head fits.
You may also be interested in...
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Among the largest gaps in safety data is non-clinical research on CBD use's effect on developing fetus and adolescent brain, in utero/lactational exposure, reproductive toxicity and the potential for a latency period before toxicity, says FDA neuroscientist Andrew Shen.
The templates from the US agency provide guidance to manufacturers developing antibody tests for clinical or at-home use.